Mpox is a rare viral infection, with a recent increase in cases throughout many parts of the world, including Canada. The virus spreads through close, physical contact, particularly through contact with an infected person’s rash or bodily fluids such as blood, saliva, and semen. The virus may also spread through respiratory particles (e.g. from talking, breathing, coughing, sneezing) during prolonged close contact.
Symptoms include:
- Rash (sometimes painful) on mouth, genitals, face, arm and legs, and feet and hands
- Fever
- Chills
- Swollen glands
- Headache
- Muscle and joint pain
- Exhaustion
People usually develop symptoms 5 to 21 days after exposure are contagious from the onset of symptoms until skin has healed.
If students experience symptoms, they should stay away from others and contact a healthcare provider immediately for advice on testing and medical care. This viral infection typically goes away on its own within 2-4 weeks but, in some cases, it can be severe and potentially life-threatening.
Mpox Vaccine
People who are eligible can get a two-dose vaccine which can be used to protect against Mpox (i.e., (Pre-Exposure Prophylaxis – PrEP) or after exposure (i.e., Post-Exposure Prophylaxis – PEP).
For more information about Mpox including who is eligible for the vaccine, see the and/or the websites.